skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 9,956  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Heart Failure remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
Material Type:
Article
Add to My Research

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes

The New England journal of medicine, 2020-10, Vol.383 (15), p.1425-1435 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2004967

Full text available

2
Relation of serum uric acid levels to readmission and mortality in patients with heart failure
Material Type:
Article
Add to My Research

Relation of serum uric acid levels to readmission and mortality in patients with heart failure

Scientific reports, 2023-10, Vol.13 (1), p.18495-18495, Article 18495 [Peer Reviewed Journal]

The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-023-45624-z ;PMID: 37898627

Full text available

3
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
Material Type:
Article
Add to My Research

Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

New England Journal of Medicine, 2020-06, Vol.382 (25), p.2462-2464 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright Massachusetts Medical Society Jun 18, 2020 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2007621 ;PMID: 32356626

Digital Resources/Online E-Resources

4
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial
Material Type:
Article
Add to My Research

Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial

The Lancet (British edition), 2021-09, Vol.398 (10304), p.991-1001 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01754-2

Full text available

5
Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review
Material Type:
Article
Add to My Research

Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review

Journal of the American College of Cardiology, 2020-02, Vol.75 (4), p.422-434 [Peer Reviewed Journal]

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;2020. American College of Cardiology Foundation ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.11.031 ;PMID: 32000955

Full text available

6
A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report
Material Type:
Article
Add to My Research

A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report

The New England journal of medicine, 2019-04, Vol.380 (17), p.1618-1627 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1900486 ;PMID: 30883052

Full text available

7
Initial Invasive or Conservative Strategy for Stable Coronary Disease
Material Type:
Article
Add to My Research

Initial Invasive or Conservative Strategy for Stable Coronary Disease

The New England journal of medicine, 2020-04, Vol.382 (15), p.1395-1407 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1915922 ;PMID: 32227755

Full text available

8
Transcatheter Repair for Patients with Tricuspid Regurgitation
Material Type:
Article
Add to My Research

Transcatheter Repair for Patients with Tricuspid Regurgitation

The New England journal of medicine, 2023-05, Vol.388 (20), p.1833-1842 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2300525 ;PMID: 36876753

Full text available

9
Correction: Increased Levels of Plasma Soluble Sema4D in Patients with Heart Failure
Material Type:
Article
Add to My Research

Correction: Increased Levels of Plasma Soluble Sema4D in Patients with Heart Failure

PloS one, 2019-03, Vol.14 (3), p.e0214894-e0214894 [Peer Reviewed Journal]

COPYRIGHT 2019 Public Library of Science ;COPYRIGHT 2019 Public Library of Science ;2019 Lu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Lu et al 2019 Lu et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0214894 ;PMID: 30921442

Full text available

10
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Material Type:
Article
Add to My Research

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Circulation (New York, N.Y.), 2022-05, Vol.145 (18), p.e895-e1032 [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/cir.0000000000001063 ;PMID: 35363499

Full text available

11
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Material Type:
Article
Add to My Research

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022-03, Vol.28 (3), p.568-574 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;EISSN: 1744-7933 ;DOI: 10.1038/s41591-021-01659-1 ;PMID: 35228754

Full text available

12
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Material Type:
Article
Add to My Research

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

The New England journal of medicine, 2021-10, Vol.385 (16), p.1451-1461 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2107038 ;PMID: 34449189

Full text available

13
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Material Type:
Article
Add to My Research

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

The New England journal of medicine, 2022-09, Vol.387 (12), p.1089-1098 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2206286 ;PMID: 36027570

Full text available

14
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
Material Type:
Article
Add to My Research

SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

The Lancet (British edition), 2022-09, Vol.400 (10354), p.757-767 [Peer Reviewed Journal]

Copyright © 2022 Published by Elsevier Ltd. All rights reserved. Published by Elsevier Ltd.. All rights reserved. ;2022. Published by Elsevier Ltd. All rights reserved ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01429-5 ;PMID: 36041474

Full text available

15
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Material Type:
Article
Add to My Research

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Journal of the American College of Cardiology, 2022-05, Vol.79 (17), p.1757-1780 [Peer Reviewed Journal]

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.12.011 ;PMID: 35379504

Full text available

16
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
Material Type:
Article
Add to My Research

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

The Lancet (British edition), 2022-12, Vol.400 (10367), p.1938-1952 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)02076-1 ;PMID: 36356631

Full text available

17
Empagliflozin in Patients with Chronic Kidney Disease
Material Type:
Article
Add to My Research

Empagliflozin in Patients with Chronic Kidney Disease

The New England journal of medicine, 2023-01, Vol.388 (2), p.117-127 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2204233 ;PMID: 36331190

Full text available

18
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Material Type:
Article
Add to My Research

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Journal of the American College of Cardiology, 2022-05, Vol.79 (17), p.e263-e421 [Peer Reviewed Journal]

Copyright © 2022 American Heart Association, Inc., the American College of Cardiology Foundation, and the Heart Failure Society of America. Published by Elsevier Inc. All rights reserved. ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.12.012 ;PMID: 35379503

Full text available

19
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Material Type:
Article
Add to My Research

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

The New England journal of medicine, 2020-10, Vol.383 (15), p.1413-1424 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2022190 ;PMID: 32865377

Full text available

20
GW29-e0530 Time of the echocardiographic response to cardiac resynchronization therapy and long-term mortality in patients with congestive heart failure
Material Type:
Article
Add to My Research

GW29-e0530 Time of the echocardiographic response to cardiac resynchronization therapy and long-term mortality in patients with congestive heart failure

Journal of the American College of Cardiology, 2018-10, Vol.72 (16), p.C163-C163 [Peer Reviewed Journal]

2018 ;Copyright Elsevier Limited Oct 16, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.08.738

Full text available

Results 1 - 20 of 9,956  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (9,725)

Refine My Results

Creation Date 

From To
  1. Before 1963  (36)
  2. 1963 To 1986  (38)
  3. 1987 To 1999  (119)
  4. 2000 To 2012  (662)
  5. After 2012  (9,110)
  6. More options open sub menu

Language 

  1. English  (9,934)
  2. Japanese  (759)
  3. Norwegian  (30)
  4. German  (16)
  5. Portuguese  (15)
  6. French  (4)
  7. Chinese  (3)
  8. Polish  (2)
  9. Italian  (2)
  10. Spanish  (2)
  11. Swedish  (1)
  12. More options open sub menu

Searching Remote Databases, Please Wait